Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy

被引:145
作者
Yamamoto, Y [1 ]
Maeshima, Y [1 ]
Kitayama, H [1 ]
Kitamura, S [1 ]
Takazawa, Y [1 ]
Sugiyama, H [1 ]
Yamasaki, Y [1 ]
Makino, H [1 ]
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Med & Clin Sci, Okayama 7008558, Japan
关键词
D O I
10.2337/diabetes.53.7.1831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the early stage of diabetic nephropathy (one of the major microvascular complications of diabetes) glomerular hyperfiltration and hypertrophy are observed. It is clinically important to regulate glomerular hypertrophy for preventing glomerulosclerosis. The number of glomerular endothelial cells is known to be increased in diabetic nephropathy associated with enlarged glomerular tufts, suggesting that the mechanism is similar to that of angiogenesis. Tumstatin peptide is an angiogenesis inhibitor derived from type IV collagen and inhibits in vivo neovascularization induced by vascular endothelial growth factor (VEGF), one of the mediators of glomerular hypertrophy in diabetic nephropathy. Here, we show the effect of tumstatin peptide in inhibiting alterations in early diabetic nephropathy. Glomerular hypertrophy, hyperfiltration, and albuminuria were suppressed by tumstatin peptide (1 mg/kg) in streptozotocin-induced diabetic mice. Glomerular matrix expansion, the increase of total glomerular cell number and glomerular endothelial cells (CD31 positive), and monocyte/macrophage accumulation was inhibited by tumstatin peptide. Increase in renal expression of VEGF, flk-1, and angiopoietin-2, an antagonist of angiopoietin-1, was inhibited by tumstatin treatment in diabetic mice. Alteration of glomerular nephrin expression, a podocyte protein crucial for maintaining glomerular filtration barrier, was recovered by tumstatin in diabetic mice. Taken together, these results demonstrate the potential use of antiangiogenic tumstatin peptide as a novel therapeutic agent in early diabetic nephropathy.
引用
收藏
页码:1831 / 1840
页数:10
相关论文
共 48 条
  • [1] Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy
    Aaltonen, P
    Luimula, P
    Åström, E
    Palmen, T
    Grönholm, T
    Palojoki, E
    Jaakkola, I
    Ahola, H
    Tikkanen, I
    Holthöfer, H
    [J]. LABORATORY INVESTIGATION, 2001, 81 (09) : 1185 - 1190
  • [2] Bonnet F, 2001, DIABETOLOGIA, V44, P874
  • [3] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [4] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [5] Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II
    Doublier, S
    Salvidio, G
    Lupia, E
    Ruotsalainen, V
    Verzola, D
    Deferrari, G
    Camussi, G
    [J]. DIABETES, 2003, 52 (04) : 1023 - 1030
  • [6] Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome
    Doublier, S
    Ruotsalainen, V
    Salvidio, G
    Lupia, E
    Biancone, L
    Conaldi, PG
    Reponen, P
    Tryggvason, K
    Camussi, G
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05) : 1723 - 1731
  • [7] Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
    Eremina, V
    Sood, M
    Haigh, J
    Nagy, A
    Lajoie, G
    Ferrara, N
    Gerber, HP
    Kikkawa, Y
    Miner, JH
    Quaggin, SE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) : 707 - 716
  • [8] Ferrara N, 2000, RECENT PROG HORM RES, V55, P15
  • [9] Role of vascular endothelial growth factor in the regulation of angiogenesis
    Ferrara, N
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (03) : 794 - 814
  • [10] Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease
    Flyvbjerg, A
    [J]. DIABETOLOGIA, 2000, 43 (10) : 1205 - 1223